Chongqing Zhifei Biological Products Co., Ltd. (SHE:300122)

Market Cap	30.54B -41.7%
Revenue (ttm)	8.05B -36.7%
Net Income	-14.93B
EPS	-6.24
Shares Out	2.39B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	33,589,348
Open	13.64
Previous Close	12.76
Day's Range	12.27 - 13.64
52-Week Range	11.07 - 23.49
Beta	0.46
Analysts	Buy
Price Target	15.40 (+22.13%)
Earnings Date	Aug 29, 2026

About SHE:300122

Chongqing Zhifei Biological Products Co., Ltd., a biopharmaceutical company, engages in the research and development, production, sale, and distribution of vaccine and biological products in China. The company offers recombinant COVID-19 vaccine; recombinant mycobacterium tuberculosis fusion protein products; group A and C meningococcal polysaccharide vaccine; ACYW135 meningococcal polysaccharide vaccine; Haemophilus Influenza type B conjugate vaccine; mycobacterium injection under the Vaccae brand; and meningococcal group A and C conjugate vac...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2002
• Employees: 6,292
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300122

Analyst Summary

According to 3 analysts, the average rating for 300122 stock is "Buy." The 12-month stock price target is ¥15.40, which is an increase of 22.13% from the latest price.

Price Target

¥15.40

(22.13% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 11, 2026

Data Sources Report a data error